Literature DB >> 23279439

Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease.

J J Ferreira1, R Katzenschlager, B R Bloem, U Bonuccelli, D Burn, G Deuschl, E Dietrichs, G Fabbrini, A Friedman, P Kanovsky, V Kostic, A Nieuwboer, P Odin, W Poewe, O Rascol, C Sampaio, M Schüpbach, E Tolosa, C Trenkwalder, A Schapira, A Berardelli, W H Oertel.   

Abstract

OBJECTIVE: To summarize the 2010 EFNS/MDS-ES evidence-based treatment recommendations for the management of Parkinson's disease (PD). This summary includes the treatment recommendations for early and late PD.
METHODS: For the 2010 publication, a literature search was undertaken for articles published up to September 2009. For this summary, an additional literature search was undertaken up to December 2010. Classification of scientific evidence and the rating of recommendations were made according to the EFNS guidance. In cases where there was insufficient scientific evidence, a consensus statement ('good practice point') is made. RESULTS AND
CONCLUSIONS: For each clinical indication, a list of therapeutic interventions is provided, including classification of evidence.
© 2012 The Author(s) European Journal of Neurology © 2012 EFNS.

Entities:  

Mesh:

Year:  2013        PMID: 23279439     DOI: 10.1111/j.1468-1331.2012.03866.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  78 in total

1.  Bilateral subthalamic stimulation for advanced Parkinson disease: early experience at an Eastern center.

Authors:  Shang-Ming Chiou; Yu-Chin Lin; Ming-Kuei Lu; Chon-Haw Tsai
Journal:  Neurol Sci       Date:  2014-11-14       Impact factor: 3.307

Review 2.  Carbidopa/Levodopa ER Capsules (Rytary(®), Numient™): A Review in Parkinson's Disease.

Authors:  Sarah L Greig; Kate McKeage
Journal:  CNS Drugs       Date:  2016-01       Impact factor: 5.749

3.  Modafinil: Parkinson disease-related somnolence.

Authors:  Joyce A Generali; Dennis J Cada
Journal:  Hosp Pharm       Date:  2014-07

Review 4.  Opicapone: A Review in Parkinson's Disease.

Authors:  Lesley J Scott
Journal:  Drugs       Date:  2016-09       Impact factor: 9.546

Review 5.  MR-guided focused ultrasound: a new generation treatment of Parkinson's disease, essential tremor and neuropathic pain.

Authors:  Pawel Piotr Dobrakowski; Agnieszka Kamila Machowska-Majchrzak; Beata Labuz-Roszak; Krzysztof Grzegorz Majchrzak; Ewa Kluczewska; Krystyna Barbara Pierzchała
Journal:  Interv Neuroradiol       Date:  2014-06-17       Impact factor: 1.610

Review 6.  Early versus delayed initiation of pharmacotherapy in Parkinson's disease.

Authors:  Matthias Löhle; Carl-Johan Ramberg; Heinz Reichmann; Anthony H V Schapira
Journal:  Drugs       Date:  2014-04       Impact factor: 9.546

Review 7.  Parkinsonian syndromes.

Authors:  David R Williams; Irene Litvan
Journal:  Continuum (Minneap Minn)       Date:  2013-10

Review 8.  Levodopa/Carbidopa Enteral Suspension: A Review in Advanced Parkinson's Disease.

Authors:  Sheridan M Hoy
Journal:  Drugs       Date:  2019-10       Impact factor: 9.546

9.  Efficacy of Rotigotine at Different Stages of Parkinson's Disease Symptom Severity and Disability: A Post Hoc Analysis According to Baseline Hoehn and Yahr Stage.

Authors:  Nir Giladi; Anthony P Nicholas; Mahnaz Asgharnejad; Elisabeth Dohin; Franz Woltering; Lars Bauer; Werner Poewe
Journal:  J Parkinsons Dis       Date:  2016-10-19       Impact factor: 5.568

10.  NMR-Based Metabolomics Reveal a Recovery from Metabolic Changes in the Striatum of 6-OHDA-Induced Rats Treated with Basic Fibroblast Growth Factor.

Authors:  Hong Zheng; Liangcai Zhao; Huanhuan Xia; Cuicui Xu; Dan Wang; Kun Liu; Li Lin; Xiaokun Li; Zhihan Yan; Hongchang Gao
Journal:  Mol Neurobiol       Date:  2015-12-09       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.